Warning signs include: Dizziness upon standing Decreased urination or dark urine Dry mouth and increased thirst Muscle weakness or cramping Other Concerning Symptoms Immediate medical attention is warranted if fatigue occurs with: Severe abdominal pain (may indicate pancreatitis) Right upper quadrant pain, fever, or yellowing of skin/eyes (signs of gallbladder disease) Persistent vomiting preventing fluid intake Visual changes or severe headache (especially in patients with diabetes and retinopathy) Chest pain or shortness of breath Signs of allergic reaction (rash, swelling, difficulty breathing) The American Diabetes Association Standards of Care recommend regular monitoring of patients on GLP-1 receptor agonists, including assessment of tolerability, glycemic control, weight changes, and overall well-being
Hence, the T cell dilemma is the following: be as specific as possible to target foreign danger and spare self, while being able to react to a large spectrum of body-threatening situations
Migraines usually arent known as side effects
The growth of the GLP-1 market is pushing manufacturers beyond basic sugar reduction toward higher nutritional density. This includes accelerating development of products that combine sugar reduction with metabolic health, and increasing demand for integrated solutions that deliver satiety, glycemic control, and nutritional value simultaneously. Meanwhile, Cargill warns brands and formulators against assuming GLP-1 users will swallow premium pricing automatically
Cover Image Credit: / 123RF.com (Licensed)
